Reducing asthma exacerbations in vulnerable children through a medical-legal partnership

Anne S Mainardi1, Drew Harris2, Alice Rosenthal3

  • 1Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of MedicineNew Haven, CT.

Insights

A Medical-Legal Partnership (MLP) significantly reduced asthma exacerbation encounters and hospitalizations in urban children. This intervention shows promise for decreasing health disparities in pediatric asthma care.

Area of Science:

  • Pediatric Healthcare
  • Health Disparities Research
  • Public Health Interventions

Background:

  • Asthma disproportionately affects children from low-income families, leading to worse health outcomes.
  • Medical-Legal Partnerships (MLPs) integrate legal services within healthcare settings to address social determinants of health.
  • This study investigated the impact of an MLP on asthma exacerbation rates in a vulnerable urban pediatric population.

Purpose of the Study:

  • To evaluate the effectiveness of a Medical-Legal Partnership (MLP) intervention in reducing asthma exacerbation healthcare utilization.
  • To assess changes in primary care, emergency department, and inpatient encounters for asthma exacerbations before and after MLP referral.

Main Methods:

  • A retrospective study of 98 children with asthma referred to an MLP between 2013 and 2017.
  • Comparison of healthcare utilization for asthma exacerbations in the year preceding and the year following MLP intervention.
  • Analysis included encounters in primary care, emergency departments, and inpatient settings.

Main Results:

  • Total asthma-related encounters per patient per year decreased by 44.2% (from 1.16 to 0.66, p < 0.01).
  • Hospitalizations for asthma exacerbations saw a significant reduction of 69.7% (from 0.33 to 0.10 per patient per year, p < 0.01).
  • Reductions in primary care and emergency department encounters were observed but did not reach statistical significance.

Conclusions:

  • MLP intervention was associated with a significant decrease in asthma exacerbation encounters and hospitalizations in a pediatric population.
  • MLPs represent a potential strategy for mitigating health disparities in children with asthma.
  • Further research is needed to identify optimal MLP interventions and patient subgroups that benefit most.
Abstract

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.3K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
797
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
642